Dihydroxyphenylacetic acid conjugate: natural occurrence and demonstration of probenecid-induced accumulation in rat striatum, olfactory tubercles and frontal cortex. 1977

M A Elchisak, and J W Maas, and R H Roth

Methods for the synthesis of 14C-dihydroxyphenylacetic acid (DOPAC) conjugate and for the fluorometric determination of both free and conjugated DOPAC in the same tissue sample are described. Both free and conjugated DOPAC were demonstrated to occur endogenously in the rat corpus striatum, olfactoy tubercles and frontal cortical area, and the ratio of conjugated DOPAC to free DOPAC was 2-3 times greater in the olfactory tubercles and frontal cortical area than in the striatum. Probenecid administration (200 mg/kg, i.p., 4 and 2h before sacrificing) significantly increased the levels of DOPAC conjugate in all 3 brain areas studied. The levels of free DOPAC were also increased in the olfactory tubercles and frontal cortex by the probenecid treatment, but this increase was much less than that seen for DOPAC conjugate in these regions. Free DOPAC levels in the striatum were unaffected by the probenecid treatment. In all 3 brain areas studied, therefore, probenecid treatment resulted in a significant accumulation of conjugated DOPAC relative to free DOPAC. The magnitude of this effect varied, and was most marked in the frontal cortex. These results suggest that, in order for DOPAC to be transported from the central nervous system via a probenecid-sensitive transport system, it must first be conjugated. Additionally, it appears that the rates of synthesis, metabolism, and transport for both free and conjugated DOPAC may vary greatly among different dopamine-containing brain regions.

UI MeSH Term Description Entries
D008297 Male Males
D009830 Olfactory Bulb Ovoid body resting on the CRIBRIFORM PLATE of the ethmoid bone where the OLFACTORY NERVE terminates. The olfactory bulb contains several types of nerve cells including the mitral cells, on whose DENDRITES the olfactory nerve synapses, forming the olfactory glomeruli. The accessory olfactory bulb, which receives the projection from the VOMERONASAL ORGAN via the vomeronasal nerve, is also included here. Accessory Olfactory Bulb,Olfactory Tract,Bulbus Olfactorius,Lateral Olfactory Tract,Main Olfactory Bulb,Olfactory Glomerulus,Accessory Olfactory Bulbs,Bulb, Accessory Olfactory,Bulb, Main Olfactory,Bulb, Olfactory,Bulbs, Accessory Olfactory,Bulbs, Main Olfactory,Bulbs, Olfactory,Glomerulus, Olfactory,Lateral Olfactory Tracts,Main Olfactory Bulbs,Olfactorius, Bulbus,Olfactory Bulb, Accessory,Olfactory Bulb, Main,Olfactory Bulbs,Olfactory Bulbs, Accessory,Olfactory Bulbs, Main,Olfactory Tract, Lateral,Olfactory Tracts,Olfactory Tracts, Lateral,Tract, Lateral Olfactory,Tract, Olfactory,Tracts, Lateral Olfactory,Tracts, Olfactory
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

M A Elchisak, and J W Maas, and R H Roth
January 1994, Proceedings of the Western Pharmacology Society,
M A Elchisak, and J W Maas, and R H Roth
September 1987, The Journal of pharmacy and pharmacology,
M A Elchisak, and J W Maas, and R H Roth
June 1983, Japanese journal of pharmacology,
M A Elchisak, and J W Maas, and R H Roth
January 1979, Pharmacological research communications,
M A Elchisak, and J W Maas, and R H Roth
March 1973, Journal of the neurological sciences,
M A Elchisak, and J W Maas, and R H Roth
January 1991, Brain research,
M A Elchisak, and J W Maas, and R H Roth
September 1979, Journal of neurochemistry,
M A Elchisak, and J W Maas, and R H Roth
September 1976, European journal of pharmacology,
M A Elchisak, and J W Maas, and R H Roth
January 1979, Analytical biochemistry,
Copied contents to your clipboard!